Showing results (1851-1860 of 1,919) with videos related to
Sort By:
Pageof 192
Microbial Ecology|March 20, 2013
Clonally related methicillin-resistant Staphylococcus aureus isolated from short-finned pilot whales (Globicephala macrorhynchus), human volunteers, and a bayfront cetacean rehabilitation facilitySuzanne Hower, Matthew C Phillips, Micah Brodsky, et al.The Journal of Organic Chemistry|January 8, 2021
Design, Synthesis, and Biological Investigation of Thailanstatin A and Spliceostatin D Analogues Containing Tetrahydropyran, Tetrahydrooxazine, and Fluorinated Structural MotifsK C Nicolaou, Santhosh Reddy Rekula, S Mothish Kumar, et al.Frontiers in Genetics|September 25, 2020
A Comparison of Forensic Age Prediction Models Using Data From Four DNA Methylation TechnologiesA Freire-Aradas, E Pośpiech, A Aliferi, et al.Blood|January 31, 2023
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemiaStephen K Tahir, Emiliano Calvo, Benedito A Carneiro, et al.The Journal of Clinical Investigation|July 4, 2012
Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolismAlanna Strong, Qiurong Ding, Andrew C Edmondson, et al.Human Gene Therapy|December 1, 2022
T Cell Responses to Dystrophin in a Natural History Study of Duchenne Muscular DystrophyKaren Anthony, Pierpaolo Ala, Francesco Catapano, et al.Elife|December 23, 2025
Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically diverse <i>Caenorhabditis</i> nematodesStephen A Banse, Christine A Sedore, Anna Coleman-Hulbert, et al.Health Affairs Scholar|February 7, 2025
Sustainable solutions to the continuous threat of antimicrobial resistanceBrad Spellberg, David N Gilbert, Michael Baym, et al.Leukemia|December 13, 2019
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignanciesDarren C Phillips, Sha Jin, Gareth P Gregory, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2020
Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative ColitisJulia Fritsch, Luis Garces, Maria A Quintero, et al.Pageof 192